JPH0528143B2 - - Google Patents
Info
- Publication number
- JPH0528143B2 JPH0528143B2 JP63064210A JP6421088A JPH0528143B2 JP H0528143 B2 JPH0528143 B2 JP H0528143B2 JP 63064210 A JP63064210 A JP 63064210A JP 6421088 A JP6421088 A JP 6421088A JP H0528143 B2 JPH0528143 B2 JP H0528143B2
- Authority
- JP
- Japan
- Prior art keywords
- fibers
- tube
- artificial blood
- blood vessel
- fluff
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000835 fiber Substances 0.000 claims description 53
- 210000004204 blood vessel Anatomy 0.000 claims description 36
- 239000002473 artificial blood Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 18
- 239000004744 fabric Substances 0.000 claims description 17
- 229920001410 Microfiber Polymers 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 125000006850 spacer group Chemical group 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000009940 knitting Methods 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- -1 polytetrafluoroethylene Polymers 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 3
- 230000003872 anastomosis Effects 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000009941 weaving Methods 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000008692 neointimal formation Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229950011008 tetrachloroethylene Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、繊維によつてチユーブ形成された耐
ほつれ性、抗血栓性、吻合性に優れた人工血管の
製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a method for producing an artificial blood vessel formed into a tube of fibers and having excellent fraying resistance, antithrombotic properties, and anastomotic properties.
(従来の技術)
従来の織編物による人工血管は、ポリエステル
繊維で形成された織物または編物であり、しかも
人工血管壁からの漏血防止の必要から非常に高密
度な、すなわち目の詰まつた織編物より成つてい
る。(Prior Art) Conventional artificial blood vessels made of woven or knitted fabrics are woven or knitted fabrics made of polyester fibers, and are very dense, that is, tightly packed, in order to prevent blood leakage from the walls of the artificial blood vessels. It is made of woven or knitted fabric.
(発明が解決しようとする問題点)
特に織物から成る人工血管は、そのために術中
の針通過性が悪く、生体血管との吻合が極めて困
難であり、手術者に過大の負担を余儀なくしてい
る。また、単純な織組織のみによる簡素な組織で
あるため、縫い針通過後や生体血管との結合時に
ほつれが生じ吻合不全となり易い。最悪の場合は
血液が洩れて即死という致命的な欠陥となる。そ
こで、従来の耐ほつれ性や針通過性の改善として
採られた手段は、例えば特開昭53−137599号公報
の如く非常に複雑な経編組織による編成であつ
た。そのため編組織を複雑にする必要から使用す
る糸の繊度は必然的に細くせざるを得ず、しかも
編機も非常に特殊で高精度なものを必要とした。(Problems to be Solved by the Invention) Artificial blood vessels made of textiles in particular have poor needle passability during surgery and are extremely difficult to anastomose with biological blood vessels, placing an excessive burden on the operator. . In addition, since it is a simple tissue consisting of only a simple woven tissue, fraying occurs after passing through a sewing needle or when connected to a biological blood vessel, resulting in anastomosis failure. In the worst case scenario, blood may leak and cause instant death, a fatal flaw. Therefore, the conventional means taken to improve fraying resistance and needle passability has been knitting using a very complicated warp knitting structure, as disclosed in, for example, Japanese Patent Application Laid-Open No. 137599/1983. For this reason, the knitting structure had to be complicated, so the fineness of the yarn used had to be made finer, and the knitting machine needed to be very special and highly precise.
本発明者らは、人工血管として致命的欠陥であ
る上記問題点について鋭意検討した結果、本発明
に到達した。 The present inventors have arrived at the present invention as a result of intensive study on the above-mentioned problem, which is a fatal defect in artificial blood vessels.
(問題点を解決するための手段) 本発明は、つぎの構成を有する。(Means for solving problems) The present invention has the following configuration.
(1) 毛羽及び/又はループ状繊維を有するチユー
ブ状布帛に高圧流体処理を施す方法であつて、
該チユーブ状布帛の内側にスペーサーを挿入し
た後、高圧流体処理を施して該毛羽及び/又は
ループ状繊維の少なくとも一部を、基本組織を
構成する繊維と交絡せしめることを特徴とする
人工血管の製造方法。(1) A method of subjecting a tube-shaped fabric having fluff and/or loop-shaped fibers to high-pressure fluid treatment,
After inserting a spacer inside the tube-like fabric, high-pressure fluid treatment is performed to intertwine at least a portion of the fluff and/or loop-like fibers with fibers constituting basic tissue. Production method.
(2) チユーブ状布帛の組織を構成する繊維の少な
くとも一部が、0.5デニール以下の極細繊維で
ある特許請求の範囲第1項記載の人工血管の製
造方法。(2) The method for producing an artificial blood vessel according to claim 1, wherein at least some of the fibers constituting the tissue of the tube-like fabric are ultrafine fibers of 0.5 denier or less.
本発明において、チユーブ状布帛は、編物、織
物、組紐などいずれであつても良く、又組織の種
類を問わず任意に選択できる。また繊維も一種類
の繊維でも良いし、2種以上の繊維の混織や引き
揃えでも良い。又基本組織形成時の糸使いは1種
でも良いが、2種以上の糸使いをした方がより好
ましい。 In the present invention, the tube-like fabric may be any of knitted fabrics, woven fabrics, braided cords, etc., and can be arbitrarily selected regardless of the type of structure. Further, the fiber may be one type of fiber, or two or more types of fiber may be mixed or aligned. Also, although it is acceptable to use one type of thread during the formation of the basic structure, it is more preferable to use two or more types of thread.
また、繊維として用いるポリマーはポリエテ
ル、ポリアミド、ポリテトラフルオロエチレン、
ポリオレフインなど特にその種類を問わないが、
特にポリエステルが好ましい。多成分系繊維を用
いる場合は最終的に残るポリマーは上記ポリマー
であるが他の組み合せ成分としてはポリスチレ
ン、ポリエチレン、水溶性ポリアミド、アルカリ
水溶液可溶型ポリエステル、水溶性ポリビニルア
ルコール等を適宜組合せることが可能である。 Polymers used as fibers include polyether, polyamide, polytetrafluoroethylene,
Although it does not matter what kind it is, such as polyolefin,
Particularly preferred is polyester. When using multi-component fibers, the final polymer remaining is the above-mentioned polymer, but other combination components include polystyrene, polyethylene, water-soluble polyamide, alkaline aqueous solution-soluble polyester, water-soluble polyvinyl alcohol, etc., as appropriate. is possible.
本発明をより効果的にするためには、組織を構
成する繊維の少なくとも一部の繊維は単糸繊度が
1.0デニール以下の極細繊維を用いるのが良い。
極細繊維を用いることにより、後で述べる高圧流
による3次元交絡効果を高めると共に、非常に柔
軟でしかも漏血性の小さいいわゆるLow Porous
人工血管となる。 In order to make the present invention more effective, at least some of the fibers constituting the tissue have a single fiber fineness.
It is best to use ultrafine fibers of 1.0 denier or less.
By using ultra-fine fibers, we can enhance the three-dimensional entangling effect caused by high-pressure flow, which will be described later, and also create so-called low porous fibers that are extremely flexible and have low blood leakage.
It becomes an artificial blood vessel.
更に、極細繊維を用いることにより繊維間〓が
微細でかつ多数形成され、細胞や繊維が入り易く
なるためフイブリン沈着が極めて薄くかつ均一に
かつ強固に行なわれる。 Furthermore, by using ultrafine fibers, the interfibers are fine and numerous, making it easier for cells and fibers to enter, resulting in extremely thin, uniform, and strong fibrin deposition.
しかし、一方生体内における繊維の強度劣化や
場合によつては吸収、消失などの問題(生体内で
の一定の加水分解作用と考えられる)があり、細
ければ細い程良いと言うものではない。 However, on the other hand, there are problems such as strength deterioration of fibers in vivo, and in some cases absorption and disappearance (possibly due to a certain hydrolysis effect in vivo), so the thinner the fiber, the better. .
そのため、これらの特徴と問題点を同時に解決
するため、1.0デニール以下、より好ましくは0.5
デニール以下の極細繊維(A)と、1.0デニールを越
える、より好ましくは1.5デニールを越える繊維
(B)により人工血管の骨格を形成せしめることが好
ましい。(B)繊維により生体内での劣化を抑え、一
方極細繊維(A)を用いることにより毛羽及び/ルー
プ発現性や生体適合性、柔軟性、絡合性、針通過
性を高めることができる。 Therefore, in order to solve these characteristics and problems at the same time, the
Ultrafine fibers (A) of denier or less and fibers of more than 1.0 denier, more preferably more than 1.5 denier
It is preferable that (B) forms the skeleton of the artificial blood vessel. (B) Fibers can suppress in-vivo deterioration, while ultrafine fibers (A) can improve fuzz and/or loop development, biocompatibility, flexibility, entanglement, and needle passability.
なお、本発明で用いる繊維は、フイラメントヤ
ーンでもステープルヤーンでも良いが、人工血管
の壁厚などの点からフイラメントヤーンの方が自
在に調節できる利点がある。 The fibers used in the present invention may be filament yarns or staple yarns, but filament yarns have the advantage of being able to be adjusted more freely in terms of the wall thickness of the artificial blood vessel.
更に、人工血管には毛羽及び/又はループがあ
ると新生内膜形成性が良く、特に極細繊維の毛羽
及び/又はループがあることが好ましい。また外
壁にも周囲組織との付着性を高めるために毛羽及
び/又はループがあるのが良い場合があるが、本
発明ではこの目的を同時に達成し得る。 Furthermore, if the artificial blood vessel has fluff and/or loops, it has good neointimal formation properties, and it is particularly preferable that the artificial blood vessel has fluff and/or loops of ultrafine fibers. It may also be desirable for the outer wall to have fluff and/or loops to enhance adhesion to surrounding tissue, and the present invention can simultaneously achieve this purpose.
また、上記の極細繊維に関して、血管形成にあ
たつて、すでにかかる極細繊維の形態となつてい
る繊維をそのまま用いても良いが、化学的もしく
は物理的手段により極細化可能な繊維を用いてチ
ユーブを形成し、しかる後極細化することにより
結果的に極細繊維でチユーブが形成されるように
してもよい。極細繊維を得る方法としては通常の
紡糸方法で十分の注意を払つて得ることができる
が、ポリエステルの場合のように未延伸糸を特定
の条件下で延伸し、極細繊維となすことも可能で
ある。 Regarding the above-mentioned ultra-fine fibers, when forming blood vessels, fibers that are already in the form of ultra-fine fibers may be used as they are, but fibers that can be made ultra-fine by chemical or physical means may be used to form tubes. may be formed, and then ultra-fine to form a tube of ultra-fine fibers. Ultrafine fibers can be obtained by using normal spinning methods with due care, but it is also possible to create ultrafine fibers by stretching undrawn yarn under specific conditions, as in the case of polyester. be.
一方、後手段により極細化可能な繊維としては
例えば特公昭48−22126、特公昭53−22593等でみ
られるごとく多成分系繊維の一成分を除去する
か、もしくは剥離させるか等の手段によりフイブ
リル化もしくは極細化するタイプの繊維を意味す
る。かかる繊維の場合、チユーブ加工時は通常の
繊維の太さであつても加工後極細化できるため加
工上のトラブル例えば製織や製編や製紐時、製織
や製編前の各種の糸加工手段を講じる場合の糸切
れや毛羽発生等を最少限に抑えることができて好
ましい。 On the other hand, as fibers that can be made ultra-fine by post-processing, fibrils can be made by removing or exfoliating one component of multicomponent fibers, as seen in Japanese Patent Publication No. 48-22126, Japanese Patent Publication No. 53-22593, etc. It means a type of fiber that becomes thinner or ultra-fine. In the case of such fibers, during tube processing, even if the fiber is of normal thickness, it can be made extremely fine after processing, resulting in processing problems such as weaving, knitting, stringing, and various thread processing methods before weaving or knitting. This is preferable because it can minimize thread breakage, fuzz generation, etc. when threading.
本発明の最も特徴的な点は、人工血管のような
チユーブ状布帛に高圧流体処理を施すことにあ
る。シート状物に対する高圧流体処理は一般的に
行なわれているが、チユーブ状物、特に人工血管
に高圧流体処理を施すことは思いもよらない。な
ぜならば、チユーブ状物を偏平に折りたたんで処
理すれば、内面同士で交絡して一体化するであろ
うし、また一体化を防止するために高圧流体が貫
通しないようにすれば大量の水の逃げ場がなくな
る。 The most distinctive feature of the present invention is that high-pressure fluid treatment is applied to a tubular fabric such as an artificial blood vessel. Although high-pressure fluid treatment is commonly performed on sheet-like objects, it is unthinkable to perform high-pressure fluid treatment on tube-like objects, especially artificial blood vessels. This is because if a tube-shaped object is folded flat and processed, the inner surfaces will intertwine and become integrated, and if high-pressure fluid is prevented from penetrating to prevent integration, there will be a place where a large amount of water can escape. disappears.
そのため、交絡が生じないばかりでなく、チユ
ーブ状物の形状が保持できないと考えられるから
である。また繊維が交絡するには繊維の移動が必
須であり、そのためにはチユーブ状物の内径より
かなり小さい挿入物でなくてはならないと考えら
れるからである。 This is because not only does entanglement not occur, but also the shape of the tube-like object cannot be maintained. Further, in order for the fibers to intertwine, movement of the fibers is essential, and for this purpose, it is thought that the insert must be considerably smaller than the inner diameter of the tube-like object.
しかし、本発明者らは、鋭意検討の結果チユー
ブ状物の内側に筒状物または棒状物あるいは板状
物などのスペーサーを挿入することにより、高圧
流体処理でチユーブが内璧同士でくつついたり、
チユーブ状物がよじれたり、シワにならないよう
考慮すればば思いもかけず、本発明の初期目的を
達成できることを見出したのである。 However, as a result of extensive research, the inventors of the present invention have found that by inserting a spacer such as a cylindrical object, a rod-like object, or a plate-like object inside the tube-like object, the tube can be prevented from being pinched by the inner walls during high-pressure fluid treatment. ,
It has been unexpectedly discovered that the initial objective of the present invention can be achieved by taking care to prevent the tube-like material from twisting or wrinkling.
本発明においては、上述の如き技術思想に基ず
き、毛羽及び/又はループ状繊維の少なくとも一
部が基本組織を構成する繊維と交絡させることが
必要である。かかる構成にすることにより、耐ほ
つれ性、抗血栓性、吻合性に優れた人工血管とす
ることができる。 In the present invention, based on the above-mentioned technical concept, it is necessary that at least a portion of the fluff and/or loop-like fibers be intertwined with the fibers constituting the basic structure. With such a configuration, an artificial blood vessel with excellent fraying resistance, antithrombotic properties, and anastomotic properties can be obtained.
特に耐ほつれ性については、従来生体血管と人
工血管の縫合時または縫合後における縫合部がほ
つれやすすいため、血液が洩れて最悪の場合には
即死という致命的な欠陥となつていたが、本発明
で得られる人工血管によつて耐ほつれ性が著しく
改善される。 In particular, regarding fraying resistance, in the past, the sutured parts of living blood vessels and artificial blood vessels were easily frayed during or after suturing, resulting in blood leakage and, in the worst case, instant death, which was a fatal flaw. The fraying resistance of the artificial blood vessel obtained by the invention is significantly improved.
本発明にかかる人工血管を製造する方法とし
て、高圧流を利用する方法であるが、更に、該高
圧流を噴射する前に布帛に毛羽及び/又はループ
を形成しておくことが特に好ましい。毛羽及び/
又はループを形成する手段としては基本組織を形
成する時に行う方法、例えば、パイルやカツトパ
イル織編物などがその代表的手段であるが、サテ
ン組織などであつても良く、熱処理や薬液処理を
応用して発現した糸長差、あるいは例えば収縮差
を付与した組織の組み合せによる糸長差によるル
ープであつてもよい。又製織、製編後に起毛処
理、例えば起毛機による方法やシヤーリング機に
よる方法、場合によつてはサンドペーパーでこす
る方法などがその代表的な手段であるが、本発明
はこれらの手段にのみとらわれるものではなく、
高圧流で噴射処理する前に毛羽及び/又はループ
が形成されていることが重要なポイントである。
また場合によつては、内壁面及び外壁面とも毛
羽/又はループの発現処理をした方が良い場合も
ある。 The method of manufacturing the artificial blood vessel according to the present invention is a method that uses high-pressure flow, and it is particularly preferable to form fuzz and/or loops on the fabric before injecting the high-pressure flow. Fluff and/or
Alternatively, the loops can be formed by a method used when forming the basic structure, such as pile or cut pile woven or knitted fabrics, but satin structures may also be used, and heat treatment or chemical treatment may be applied. It may be a loop due to a yarn length difference caused by a difference in yarn length, or a yarn length difference caused by a combination of tissues that have been given a contraction difference, for example. In addition, typical methods include raising treatment after weaving or knitting, such as a method using a raising machine, a method using a shearing machine, and a method of rubbing with sandpaper in some cases, but the present invention is not limited to these methods. Not something to be held back by,
It is important that fluff and/or loops are formed before the high pressure jet treatment.
In some cases, it may be better to treat both the inner wall surface and the outer wall surface to form fuzz/loop.
高圧流による交絡処理の方法は種々考えられる
が液体による方法がより効率的であり、中でもウ
オータージエツト流による方法が安全性及び経済
性の点から最も好ましい。すなわち、5〜200
Kg/cm2のウオータージエツトパンチで小孔より毛
羽及び/又はループを有する面(場合によつては
両面に毛羽及び/又はループを有する場合もあ
る)及び/又はその裏面に噴射させる方法が良
い。噴射圧は小さ過ぎると絡まないが、大き過ぎ
ると繊維が切断されてしまつて良くない。この範
囲の中で繊維の強度やその時の繊度や束の太さ、
また人工血管の柔軟性などによつて適宜決められ
る。 Although various methods for the entanglement treatment using high-pressure flow can be considered, a method using a liquid is more efficient, and among them, a method using a water jet flow is the most preferable from the viewpoints of safety and economy. i.e. 5-200
Kg/cm 2 waterjet punch is used to spray water from a small hole onto the surface having fluff and/or loops (in some cases, both sides may have fluff and/or loops) and/or the back surface thereof. good. If the injection pressure is too low, the fibers will not become tangled, but if the injection pressure is too high, the fibers will be cut, which is not good. Within this range, the strength of the fiber, the fineness at that time, the thickness of the bundle,
In addition, it can be appropriately determined depending on the flexibility of the artificial blood vessel.
また高圧流処理は、人工血管の太さよりも大き
い部位から人工血管に向つて噴射できるような多
数の小孔を付したノズルから高圧流を噴射して行
なつても、またチユーブ状物を偏平に折りたたん
でそれと平行に位置した多数の小孔から高圧流を
噴射して行なつても良い。この場合、チユーブの
内側に筒状のネツトやプラスチツク、金属、ガラ
スや場合によつては発泡体などの水を通過するも
のやしないものの筒状物や板状物または某状物な
どのスペーサーを挿入して高圧流体処理を行なう
ことにより、チユーブが内壁同士でくつついてし
まつたりせず、後の処理が容易であると共に、場
合によつては該チユーブの直径をコントロールす
る方法の一つとして用いることができる。 In addition, high-pressure flow treatment can be performed by injecting high-pressure flow from a nozzle with many small holes that can be sprayed toward the artificial blood vessel from a part larger than the thickness of the artificial blood vessel, or by flattening a tube-shaped object. This can also be done by folding it into a shape and injecting a high-pressure stream through a number of small holes located parallel to it. In this case, a spacer such as a cylindrical net, plastic, metal, glass, or in some cases foam, which may or may not pass through water, is placed inside the tube. By inserting the tube and performing high-pressure fluid treatment, the tube does not get stuck between the inner walls, making subsequent treatment easier, and in some cases, it can be used as a method to control the diameter of the tube. Can be used.
またウオータージエツトパンチは基本組織の周
期と一致しないように、左右に揺動させたり、サ
イクリツクに揺動させることが好ましい。これに
より、パンチすじやモワレ現象を軽減させること
ができる。 Further, it is preferable that the waterjet punch be oscillated from side to side or cyclically so as not to match the period of the basic tissue. Thereby, punch lines and moire phenomena can be reduced.
更にチユーブ状物を裏返して高圧流処理を行な
うならば、より耐ほつれ性を向上し得るが、必ず
しも必要ではない。 Furthermore, if the tube-shaped article is turned over and subjected to high-pressure flow treatment, the fraying resistance can be further improved, but this is not always necessary.
また人工血管の製造においては、布帛をチユー
ブ化する必要があるが、このチユーブ化の手段と
しては、布帛と成した後裁断し、縫製や接着や融
着などの手段によつてチユーブ状物と成すことも
できるが、基本組織を形成するに際し、チユーブ
状に形成した方が継ぎ目がなくより好ましい。な
お、前者の場合、すなわち、先ずシート状物と
し、次にチユーブ状物とする場合は前述の起毛処
理等はシート状の段階で行なつてもチユーブ状物
としてから行なつても良いことはもちろんであ
る。 In addition, in the production of artificial blood vessels, it is necessary to form a fabric into a tube, and the method for forming a tube is to cut the fabric, then create a tube-like object by sewing, gluing, or fusing. However, when forming the basic structure, it is more preferable to form it into a tube shape, since there is no seam. In the former case, that is, when first forming a sheet-like object and then forming a tube-like object, the above-mentioned napping treatment etc. may be performed at the sheet-like stage or after forming the tube-like object. Of course.
(実施例)
次に実施例によつて本発明をより判り易く説明
するが、本発明の有効性や権利の範囲はこれによ
つて限定されたり制限を受けるものではない。(Examples) Next, the present invention will be explained more clearly using examples, but the validity and scope of rights of the present invention are not limited or restricted thereby.
実施例 1
タテ糸及びヨコ糸(裏糸)にポリエチレンテレ
フタレートの50デニール24フイラメントの仮ヨリ
加工糸を用い、ヨコ表糸に高分子配列体複合繊維
で島成分ポリエチレンテレフタレート78部、海成
分ポリスチレン22部、島数36島の繊維245デニー
ル40フイラメント糸を用い、いわゆる緯2重織組
織でチユーブ状に織り、内径19mmφ、長さ100cm
のチユーブを形成し、湯洗し、次いで乾燥後パー
クロルエチレンでポリスチレンを除去した。次い
で、このチユーブに起毛処理剤を付与した後、起
毛機で起毛した。Example 1 The warp yarn and the weft yarn (back yarn) were made of polyethylene terephthalate 50 denier 24 filament temporarily twisted yarn, and the weft surface yarn was a polymer array composite fiber containing 78 parts of island component polyethylene terephthalate and sea component polystyrene 22. Using 245 denier 40 filament yarn with 36 islands, it is woven into a tube shape with a so-called weft double weave structure, inner diameter 19 mmφ, length 100 cm.
A tube was formed, washed with hot water, and after drying, the polystyrene was removed with perchlorethylene. Next, a napping treatment agent was applied to this tube, and then the tube was napped using a napping machine.
得られたチユーブの直径は8.5mmφであつた。
ついで該チユーブに幅24mm、厚み0.12mmのポリス
テルフイルム(スペーサー)を挿入した後、吐出
孔径0.25mmφ、吐出孔間隔2.5mm、圧力70Kg/cm2
の条件でウオータージエツトパンチ処理をした。 The diameter of the tube obtained was 8.5 mmφ.
Next, after inserting a polyester film (spacer) with a width of 24 mm and a thickness of 0.12 mm into the tube, the discharge hole diameter was 0.25 mmφ, the discharge hole interval was 2.5 mm, and the pressure was 70 Kg/cm 2
Water jet punch treatment was performed under these conditions.
得られた人工血管は、基本組織は緯2重組織で
あるが主として極細繊維が単糸繊維間や織り目間
また繊維束間に多数絡まつていることが観察でき
た。該人工血管及びウオータージエツト前のもの
の耐ほつれ性を調べた。耐ほつれ性は人工血管の
軸に対して45度の角度でハサミで切つた後、断端
2mmの部位に縫合糸を通し、引張試験機でそのほ
つれ強さを測定した。その結果ウオータージエツ
トパンチをしないものは.01Kgであつたのに対
し、該人工血管は1.7Kgであつた。またチユーブ
の内壁および外壁の双方に毛羽及びループがあつ
た。 The basic structure of the obtained artificial blood vessel was a double-layer structure, but it was observed that a large number of ultrafine fibers were mainly entangled between single fibers, between weaves, and between fiber bundles. The fraying resistance of the artificial blood vessel and the one before water jet was examined. The fraying resistance was determined by cutting the artificial blood vessel at an angle of 45 degrees to the axis with scissors, passing a suture through the 2 mm stump, and measuring the fraying strength using a tensile tester. As a result, those who do not perform water jet punch. The weight of the artificial blood vessel was 1.7Kg, whereas the weight of the artificial blood vessel was 1.7Kg. There were also fuzz and loops on both the inner and outer walls of the tube.
実施例 2
実施例1で得られた人工血管を裏返した後、再
度同一条件でウオータージエツトパンチしたとこ
ろ、極細繊維の毛羽及び/又はループや繊維束は
実施例1より更に複雑に絡み合つているのが観察
された。Example 2 When the artificial blood vessel obtained in Example 1 was turned over and waterjet punched again under the same conditions, the fluff and/or loops and fiber bundles of the ultrafine fibers were found to be more entangled than in Example 1. It was observed that there were.
実施例 3
50デニール18フイラメントと50デニール72フイ
ラメントのポリエステル繊維を用い、2ニードル
タイプ、30Gのダブルラツシユ編機でハーフ組織
で直径20mmφのチユーブを形成し、沸騰水にて湯
洗し、次いで乾燥した後起毛処理を行なつた。起
毛後の状態を観察すると太繊度より細繊度の繊維
の方が多数起毛された毛羽やループを形成してい
た。更に該チユーブに16mmφのステンレス棒(ス
ペーサー)を挿入した後、吐出口0.3mmφ、吐出
孔間隔2.5mm、圧力75Kg/cm2の条件でウオーター
ジエツトパンチ処理をした。Example 3 Using polyester fibers of 50 denier 18 filament and 50 denier 72 filament, a tube with a diameter of 20 mmφ was formed with a half structure using a 2-needle type, 30G double lash knitting machine, washed with boiling water, and then dried. A post-raising treatment was performed. When observing the condition after raising, it was found that the fine-grained fibers formed more raised fluff and loops than the thick-fiber fibers. Furthermore, after inserting a stainless steel rod (spacer) of 16 mm in diameter into the tube, waterjet punching was performed under the conditions of a discharge port of 0.3 mm in diameter, a discharge hole interval of 2.5 mm, and a pressure of 75 kg/cm 2 .
得られた人工血管を観察してみると、太繊度繊
維にまとわりつくように細繊度が絡まつており、
それが繊維間や編み目間また繊維束間のそれぞれ
に達していることが判つた。また比較的少なくは
あるが太繊度同志や太繊度が細繊度に絡まつてい
るのも観察できた。また繊維が毛羽やループのま
まで存在していたり、該毛羽やループの一部の繊
維が繊維束間や繊維束内を突き抜けてチユーブの
内壁まで達しているのが観察できた。この人工血
管のほつれ性を調べたところ、ウオータージエツ
トパンチ処理をしないものに比して耐ほつれ性が
向上したばかりでなく、断端部に生ずる浮き糸の
脱落も極めて少なかつた。特に編終りからのほつ
れ性が非常に良くなつていた。 When we observed the obtained artificial blood vessel, we found that fine fibers were entwined with thick fibers.
It was found that it reached between the fibers, between the stitches, and between the fiber bundles. Although relatively rare, it was also observed that large fineness was intertwined with fineness. It was also observed that the fibers were present in the form of fuzz or loops, and that some fibers of the fuzz or loops penetrated between or within the fiber bundles and reached the inner wall of the tube. When the fraying resistance of this artificial blood vessel was investigated, it was found that not only was the fraying resistance improved compared to one that was not subjected to waterjet punch treatment, but there was also extremely little drop-off of floating threads that occurred at the stump. In particular, the fraying resistance from the end of the stitch was much improved.
(発明の効果) 本発明の効果を列挙すると次のようになる。(Effect of the invention) The effects of the present invention are enumerated as follows.
(1) 耐ほつれ性、抗血栓性、吻合性が飛躍的に向
上した。(1) The fraying resistance, antithrombotic properties, and anastomosis properties have been dramatically improved.
(2) 両面に同時に毛羽及び/又はループを簡単に
形成できる。(2) Fuzz and/or loops can be easily formed on both sides at the same time.
(3) 後加工における手段であるため、基本組織は
単純なものも複雑なものも随時目的に応じたも
のにできる。(3) Since it is a means for post-processing, the basic structure can be made simple or complex depending on the purpose.
(4) 起毛処理などによつて生じる抜け毛や浮き毛
を、洗い流したり、また再交絡により実質的に
無くすことができる。(4) Loss of hair or floating hair caused by hair raising treatment etc. can be substantially eliminated by washing or re-entangling.
以上のように従来技術では到底不可能であつた
問題点を一挙に解決し、非常に柔軟でかつ針通過
性と耐ほつれ性に優れ、かつ新生内膜形成に優れ
た人工血管の製造方法を見出すことができた。 As mentioned above, we have solved all the problems that were impossible with conventional technology at once, and developed a method for producing an artificial blood vessel that is extremely flexible, has excellent needle passability and fraying resistance, and has excellent neointimal formation. I was able to find out.
Claims (1)
ブ状布帛に高圧流体処理を施す方法であつて、該
チユーブ状布帛の内側にスペーサーを挿入した
後、高圧流体処理を施して該毛羽及び/又はルー
プ状繊維の少なくとも一部を、基本組織を構成す
る繊維と交絡せしめることを特徴とする人工血管
の製造方法。 2 チユーブ状布帛の組織を構成する繊維の少な
くとも一部が、0.5デニール以下の極細繊維であ
る特許請求の範囲第1項記載の人工血管の製造方
法。[Scope of Claims] 1. A method of subjecting a tubular fabric having fluff and/or looped fibers to high-pressure fluid treatment, the method comprising: inserting a spacer inside the tubular fabric, and then subjecting the tubular fabric to high-pressure fluid treatment; A method for manufacturing an artificial blood vessel, comprising intertwining at least a portion of the fluff and/or loop-like fibers with fibers constituting basic tissue. 2. The method for manufacturing an artificial blood vessel according to claim 1, wherein at least some of the fibers constituting the structure of the tube-like fabric are ultrafine fibers of 0.5 denier or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63064210A JPS63315048A (en) | 1988-03-16 | 1988-03-16 | Preparation of artificial blood vessel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63064210A JPS63315048A (en) | 1988-03-16 | 1988-03-16 | Preparation of artificial blood vessel |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59214410A Division JPS6192666A (en) | 1984-10-15 | 1984-10-15 | Artificial blood vessel and its production |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63315048A JPS63315048A (en) | 1988-12-22 |
JPH0528143B2 true JPH0528143B2 (en) | 1993-04-23 |
Family
ID=13251492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63064210A Granted JPS63315048A (en) | 1988-03-16 | 1988-03-16 | Preparation of artificial blood vessel |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63315048A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10251742B2 (en) | 2014-02-12 | 2019-04-09 | Toray Industries, Inc. | Artificial blood vessel |
-
1988
- 1988-03-16 JP JP63064210A patent/JPS63315048A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10251742B2 (en) | 2014-02-12 | 2019-04-09 | Toray Industries, Inc. | Artificial blood vessel |
Also Published As
Publication number | Publication date |
---|---|
JPS63315048A (en) | 1988-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6352898B2 (en) | ||
JPWO2019131148A1 (en) | Medical textiles | |
CN111295154A (en) | Medical fabric | |
JP5912556B2 (en) | Suture for medical device sewing, its use, and medical device sewn using the suture | |
TW201945039A (en) | Tubular fabric and base material for medical use using same | |
JPS6077764A (en) | Artificial blood vessel | |
WO2014132454A1 (en) | Suture to be used in producing medical instrument provided with sutured part, method for using same and medical instrument sewn using same | |
WO2021179468A1 (en) | Artificial blood vessel and preparation method therefor | |
JPS6158573B2 (en) | ||
JPH11164881A (en) | Medical material and manufacture thereof | |
JPH0528143B2 (en) | ||
JPH0369543B2 (en) | ||
CN103298436B (en) | Absorbable hemostatic agent deployable laparoscopically | |
JP2004149933A (en) | Stetchable nonwoven fabric | |
JP4632007B2 (en) | Body wash tool | |
JPH01126962A (en) | Preparation of medical prosthesis | |
JPH0624587B2 (en) | Artificial blood vessel | |
JP7341416B2 (en) | medical gauze | |
JPH07300749A (en) | Stretchable warp knit fabric and production thereof | |
JPH11169401A (en) | Gauze with handle | |
JPH0462741B2 (en) | ||
JPH03180555A (en) | Sheetlike material | |
JPH01260036A (en) | Ultrafine fiber knitted fabric and production thereof | |
JPH067387A (en) | Artificial blood vessel and its production | |
JP2002017758A (en) | Branch artifical blood vessel |